Page last updated: 2024-10-31

neostigmine and Behavior Disorders

neostigmine has been researched along with Behavior Disorders in 9 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19909 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KORANYI, EK1
KERENYI, AB1
SARWERFONER, GJ1
PRESWICK, G1
HENDERSON, AS1
LUDWIG, F1
MALL, G2
Risch, SC1
Janowsky, DS1
Mott, MA1
Gillin, JC1
Kalir, HH1
Huey, LY1
Ziegler, M1
Kennedy, B1
Turken, A1
Borden, H1
Clarke, MT1
Katz, H1
Abel, M1
Kohlmeyer, K1
Neubauer, H1
Sundland, D1
Gershon, S1

Trials

1 trial available for neostigmine and Behavior Disorders

ArticleYear
Central and peripheral cholinesterase inhibition: effects on anterior pituitary and sympathomimetic function.
    Psychoneuroendocrinology, 1986, Volume: 11, Issue:2

    Topics: Adrenocorticotropic Hormone; Catecholamines; Endorphins; Humans; Hydrocortisone; Male; Mental Disord

1986

Other Studies

8 other studies available for neostigmine and Behavior Disorders

ArticleYear
The psychiatric use of pacatal combined with a cholinergic agent.
    Medical services journal, Canada, 1958, Volume: 14, Issue:4

    Topics: Autonomic Agents; Cholinergic Agents; Mental Disorders; Neostigmine; Phenothiazines; Psychotherapy

1958
MYASTHENIA AND THE "ASTHENIC" SYNDROME.
    The Medical journal of Australia, 1965, Mar-06, Volume: 1, Issue:10

    Topics: Diagnosis, Differential; Drug Therapy; Humans; Hysteria; Mental Disorders; Muscular Diseases; Myasth

1965
[On the advisability of provoking anovular menstruation].
    Gynaecologia. International monthly review of obstetrics and gynecology. Revue internationale mensuelle d'obstetrique et de gynecologie. Monatsschrift fur Geburtshilfe und Gynakologie, 1951, Volume: 132, Issue:5

    Topics: Amenorrhea; Female; Humans; Menstruation; Mental Disorders; Metrorrhagia; Neostigmine

1951
[Experience with prostigmine in the treatment of involutional psychoses].
    Der Nervenarzt, 1950, May-20, Volume: 21, Issue:5

    Topics: Depressive Disorder, Major; Mental Disorders; Neostigmine; Psychotic Disorders

1950
[Experience with prostigmine therapy of involutional psychoses].
    Archiv fur Psychiatrie und Nervenkrankheiten, vereinigt mit Zeitschrift fur die gesamte Neurologie und Psychiatrie, 1950, Volume: 184, Issue:3-4

    Topics: Depressive Disorder, Major; Mental Disorders; Neostigmine; Psychotic Disorders

1950
The use of pancuronium bromide in patients receiving lithium carbonate.
    Canadian Anaesthetists' Society journal, 1974, Volume: 21, Issue:1

    Topics: Anesthesia, Inhalation; Atropine; Carbonates; Drug Synergism; Female; Humans; Lithium; Mental Disord

1974
[On the cholinergic-toxic psychosyndrome of prostigmine-treated myasthenics].
    Deutsche medizinische Wochenschrift (1946), 1966, Apr-15, Volume: 91, Issue:15

    Topics: Adult; Cholinesterase Inhibitors; Female; Humans; Male; Mental Disorders; Middle Aged; Myasthenia Gr

1966
Ditran and its antagonists in a mixed psychiatric population.
    The Journal of nervous and mental disease, 1966, Volume: 142, Issue:3

    Topics: Acridines; Adult; Cholinesterases; Female; Hallucinations; Hallucinogens; Humans; Male; Mental Disor

1966